Skip to main navigation Skip to search Skip to main content

Author Correction: Placebo use and unblinding in COVID-19 vaccine trials: recommendations of a WHO Expert Working Group (Nature Medicine, (2021), 27, 4, (569-570), 10.1038/s41591-021-01299-5)

  • The WHO ACT-Accelerator Ethics & Governance Working Group
  • University of KwaZulu-Natal
  • University of Toronto
  • University of Washington
  • Global Healthcare Consulting
  • Oxford University
  • Yenepoya University
  • University of Pennsylvania
  • Johns Hopkins University
  • Tribhuvan University
  • Universidade Federal de Minas Gerais
  • The University of Hong Kong
  • Graduate Institute
  • Tehran University of Medical Sciences
  • Institut Pasteur de Dakar
  • Universidade Federal de São Paulo
  • Western University

Research output: Contribution to journalComment/debate

1 Citation (Scopus)

Abstract

In the version of this article initially published, the affiliation for author Ehsan Shamsi-Gooshki (University of Tehran, Tehran, Iran) was incorrect. The correct affiliation is: Tehran University of Medical Sciences, Tehran, Iran. The error has been corrected in the HTML and PDF versions of the article. *A list of authors and their affiliations appears online.

Original languageEnglish
Pages (from-to)925
Number of pages1
JournalNature Medicine
Volume27
Issue number5
DOIs
Publication statusPublished - May 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Author Correction: Placebo use and unblinding in COVID-19 vaccine trials: recommendations of a WHO Expert Working Group (Nature Medicine, (2021), 27, 4, (569-570), 10.1038/s41591-021-01299-5)'. Together they form a unique fingerprint.

Cite this